Literature DB >> 4135222

New trends in the chemotherapy of tuberculosis--current aspects.

M Zierski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4135222     DOI： 10.1007/bf02097148

Source DB:  PubMed          Journal:  Pneumonologie        ISSN： 0033-4073


× No keyword cloud information.
  25 in total

1.  Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.

Authors:  H Eule; E Kärnbach; P Kaluza; H Herrmann
Journal:  Scand J Respir Dis Suppl       Date:  1973

Review 2.  [Current status of the antitubercular chemotherapy].

Authors:  K L Radenbach
Journal:  Internist (Berl)       Date:  1973-03       Impact factor: 0.743

3.  General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis.

Authors:  W Fox
Journal:  Bull Int Union Tuberc       Date:  1972-02

4.  A trial of intermittent rifampicin and ethambutol in retreatment regimens.

Authors:  M Zierski
Journal:  Scand J Respir Dis Suppl       Date:  1973

5.  Clinical aspects of side effects on intermittent rifampicin regimen.

Authors:  M Zierski
Journal:  Scand J Respir Dis Suppl       Date:  1973

6.  The importance of motivation in fully supervised ambulatory treatment.

Authors:  J Cabral
Journal:  Bull Int Union Tuberc       Date:  1972-02

7.  Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy: Central Bohemian Tuberculosis Services-WHO-British Medical Research Council investigation.

Authors:  F Polansky
Journal:  Bull Int Union Tuberc       Date:  1970-06

8.  [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].

Authors:  G Decroix; B Kreis; C Sors; J Birenbaum; M Le Lirzin; G Canetti
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1971 Jan-Feb

9.  A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.

Authors:  J R Bignall; A Lind; N Rist
Journal:  Bull Int Union Tuberc       Date:  1969-08

10.  Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.

Authors:  F Grumbach; G Canetti; M Le Lirzin
Journal:  Tubercle       Date:  1969-09
View more
  2 in total

Review 1.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

2.  A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.

Authors:  Yanmin Hu; Alireza Shamaei-Tousi; Yingjun Liu; Anthony Coates
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.